About Us

As a pharmaceutical company headquartered in Zurich, Switzerland, we develop, manufacture and internationally market well-proven and innovative pharmaceuticals in novel drug delivery forms.

We are proudly known for the quality of products, people, and service.

We are a leader in advanced drug delivery technologies with a focus on modified release and dispersible forms, for which we also hold patents.

We have a bold ambition

  • To stand out in the world of pharma
  • To be proudly different
  • To have a human face, not a corporate face

And we have a clear purpose for both B2C and B2B parts of the business

  • B2C: to make high-quality medicines accessible to patients and healthcare professionals in emerging markets
  • B2B: to be the preferred high-quality contract manufacturing and out-licensing partner

Key figures

  • Group sales

    >€585m​

    for full-year 2022

  • Sales % in emerging markets

    >88%

    in 2022

  • Employees

    2,793

    as of end of 2022

  • Manufacturing sites

    6

    Switzerland (2), Ukraine, Estonia, United Arab Emirates and South Africa

  • Regional offices

    5

    Dubai, Kyiv, Johannesburg, Moscow and Panama City